Carlos L. Arteaga
Harold C. Simmons Comprehensive Cancer Center
Carlos L. Arteaga, M.D., was appointed Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center in Dallas in September 2017. Previously, he was the Associate Director for Clinical Research, director of the Center for Cancer Targeted Therapies, and professor of Cancer Biology and Medicine at Vanderbilt-Ingram Cancer Center. In 2014–2015, he was the president of the American Association for Cancer Research.
Read biography ↓Biography, research & contributions
Carlos L. Arteaga, M.D., was appointed Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center in Dallas in September 2017. Previously, he was the Associate Director for Clinical Research, director of the Center for Cancer Targeted Therapies, and professor of Cancer Biology and Medicine at Vanderbilt-Ingram Cancer Center. In 2014–2015, he was the president of the American Association for Cancer Research.
Affiliation
Harold C. Simmons Comprehensive Cancer Center
Top Publications
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer (2016) - 2,074 citations
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics (2014) - 1,093 citations
- Transforming Growth Factor-β1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism (2001) - 1,012 citations
- Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration (2000) - 1,006 citations
- Overcoming Endocrine Resistance in Breast Cancer (2020) - 954 citations
At a glance
- Full name
- Carlos L. Arteaga
- ORCID
- 0000-0003-0870-9586
- OpenAlex ID
- https://openalex.org/A5043946489
Research interests
- HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Advanced Breast Cancer Therapies
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer ↗2016 · New England Journal of Medicine2,074OpenAlex citations
- 1,093OpenAlex citations
- Transforming Growth Factor-β1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism ↗2001 · Molecular Biology of the Cell1,012OpenAlex citations
- Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration ↗2000 · Journal of Biological Chemistry1,006OpenAlex citations
- Overcoming Endocrine Resistance in Breast Cancer ↗2020 · Cancer Cell954OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer ↗2016 · New England Journal of Medicine
- Transforming Growth Factor-β1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism ↗2001 · Molecular Biology of the Cell
- Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration ↗2000 · Journal of Biological Chemistry
- Overcoming Endocrine Resistance in Breast Cancer ↗2020 · Cancer Cell
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 23:44:11
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.